Tigerlily Foundation’s Post

I was proud to join Maimah Karmo of Tigerlily Foundation in authoring a new opinion piece published this week in the Richmond Times-Dispatch. In the piece, we highlight how state prescription drug affordability boards (#PDABs) have yet to demonstrate real savings for patients at the pharmacy counter and instead create barriers to accessing lifesaving treatments. Here are three key takeaways Maimah and I share in the piece: ➡️ Upper payment limits (also known as UPLs), the singular tool many PDABs can use to set prices, will NOT lower out-of-pocket costs for patients and could negatively impact the supply chain. ➡️ The impact of these boards would be particularly acute for older Americans if PDABs continue to focus on medicines that help patients manage chronic conditions and comorbidities. ➡️ Virginia lawmakers must prioritize solutions that provide real relief to patients at the pharmacy without negatively impacting treatment access today and in the future. Policies that advance health equity, promote opportunities for healthy aging, and enable the development of treatments that can support the silver economy are essential. We must continue to work toward this goal in the upcoming legislative session in my home state of Virginia and in states across the country. Drop a comment here if you want to connect and discuss how GCOA is engaging on this issue.   You can read our full opinion here: https://bit.ly/4grijsG.